ERcast: Clinical Perspectives Podcast Preview

Subscription Required

Affordable Meds & Toxic Kids

Anne Steckowych, APRN, Brett Murray, MD, Geoffrey Comp, DO, FACEP, Sarah DiVello, PharmD, and Jess Rivera Pescatore, PharmD

Sign in or Subscribe to listen.
5 starson Spotify
Sign in or Subscribe to view.Sign in or Subscribe to view.

The summary below is from an episode of ERcast: Clinical Perspectives

Medication affordability is a major determinant of whether ED discharge plans succeed. Small prescribing choices like formulation, treatment duration, and pharmacist substitution can meaningfully change adherence. In toddlers, poisonings are usually exploratory and benign, but a short list of exposures can be life-threatening after a single pill or small sip.

Lower-Cost ED Prescribing Pearls

  • Formulation cost traps: Immediate-release tablets and capsules are usually far cheaper than liquids, ODTs, or extended-release products, and that single switch often matters more for adherence than the drug choice itself.
  • Topicals and combo products: Creams or ointments are usually less expensive than foams, gels, or lotions, and combo products like doxylamine-pyridoxine often cost more than buying the ingredients separately.
  • Practical OTC substitutions: OTC 4% lidocaine patches perform similarly to prescription 5% patches for many patients, and explicit dosing instructions can make ibuprofen, naproxen, or bowel regimens prescription-free.
  • Antibiotic cost discipline: Older narrow-spectrum agents like cephalexin, amoxicillin, doxycycline, and TMP-SMX remain inexpensive workhorses, and many common infections only need 5 to 7 days of therapy.
  • Pharmacist substitution language: A simple note allowing insurance-preferred equivalent formulations can prevent callbacks and treatment delays, especially with doxycycline forms, albuterol inhalers, and tablet-versus-capsule coverage. We get into the wording nuances in the episode.
  • Hidden savings resources: Starter-pack coupons for apixaban or rivaroxaban can erase the first month cost, and 340B outpatient pharmacies may beat retail cash prices even when patients check GoodRx.

Pediatric One-Pill-Kills

  • Why children decompensate fast: Young children reach toxic doses quickly because of low body weight, limited glycogen stores, and poor cardiopulmonary reserve, so a well-appearing toddler can crash within hours.
  • Scene-based ingestion history: Unwitnessed pediatric ingestions demand detective work: inventory the home, inspect for empty containers or pill fragments, and confirm whether the product was immediate- or extended-release.
  • Early poison center partnership: Poison Control should be called early because observation, triage, and disposition often hinge on the exact product rather than the child's initial appearance. We walk through that framing in the chapter.
  • High-risk prescription exposures: Buprenorphine, methadone, clonidine, guanfacine, propranolol, calcium channel blockers, sulfonylureas, and benzonatate can all cause severe toxicity after very small pediatric exposures.
  • Named toxic red flags: Propranolol can produce sodium-channel blockade with QRS widening, methadone adds QT prolongation risk, and sulfonylureas are notorious for profound delayed hypoglycemia.
  • Dangerous household products: Camphor can trigger rapid seizures, oil of wintergreen is an extremely concentrated salicylate source, and only a few milliliters of methanol or ethylene glycol may require antidotal therapy.

Subscribe to ERcast: Clinical Perspectives to listen to the episode.

Medication Cost Resources

  • Cash-paying patients
    • Hospital outpatient pharmacies participating in the 340B program often offer substantially lower inhaler prices than commercial pharmacies.
  • Pharmacists remain the most valuable resource for identifying affordable therapeutic alternatives.
  • GoodRx can help patients compare medication prices across retail pharmacies.
  • Hospital outpatient pharmacies may still offer lower prices than discount programs for some medications.

Faculty